THRD — Third Harmonic Bio Share News
0.000.00%
- $242.79m
- -$28.82m
U.S. STOCKS ON THE MOVE-Reviva, AbCellera, Verizon
Brief: Third Harmonic Bio Announces Discontinuation Of Phase 1B Study Of Thb001 In Chronic Inducible Urticaria
Third Harmonic Bio down on discontinuation of inflammation drug study
Brief: Third Harmonic Bio Announces Third Quarter 2022 Financial Results
U.S. STOCKS ON THE MOVE-Immunic, Novavax, PayPal
U.S. STOCKS ON THE MOVE-Satsuma, defense stocks, Top Ships
U.S. STOCKS ON THE MOVE-Ford, Merck, Third Harmonic Bio
Two brokerages bullish about Third Harmonic; see blockbuster potential in hives drug
U.S. STOCKS ON THE MOVE-AST SpaceMobile, Third Harmonic Bio, BrainStorm
AIG's Corebridge slips in tepid debut
Brief: Third Harmonic Bio Shares Open 20.6% Above IPO Price in Nasdaq Debut
Third Harmonic Bio pops after IPO upsize